As the US marches toward Pot legalization --
**Cannabix Technologies Inc.** **\[ US OTC:** [**BLOZF**](http://www.otcmarkets.com/stock/BLOZF/quote)**,** **CSE:** [**BLO**](http://www.cnsx.ca/CNSX/Securities/Technology/Cannabix-Technologies-Inc.aspx)**,** **Frankfurt:** [**8CT**](http://www.boerse-frankfurt.de/aktie/cannabix-techs-inc) **\], a technology** company, is developing a **Marijuana Breathalyzer** for law enforcement and workplace employers in North America.
Today, they offered this Press Release about development progress:
These are drug-testing devices that will use breath samples to detect THC at roadside and identify drivers under the influence of marijuana. Cannabix Technologies Inc. is based in Burnaby, Canada.
In January 2021, **Cannabix** was awarded their first U.S. Patent, and their stock price immediately doubled. Also early this year, the Alipour Medical Centre, an occupational health clinic in Newport Beach, California, will begin beta testing **Cannabix**’s version 3.0 THC Breath Analyzer.